Drugs.com - Pharma Industry News

PTLD Up for Seronegative Recipients of Epstein-Barr Virus-Seropositive Donor Kidneys

WEDNESDAY, Feb. 5, 2025 -- Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R−) kidneys have an increased risk for posttransplant lymphoproliferative disorder (PTLD), according to a study published online Jan...

Feb 9, 2025 - 22:25
 0
PTLD Up for Seronegative Recipients of Epstein-Barr Virus-Seropositive Donor Kidneys
WEDNESDAY, Feb. 5, 2025 -- Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R−) kidneys have an increased risk for posttransplant lymphoproliferative disorder (PTLD), according to a study published online Jan...
Read More

Tags:

Previous Article

Baseline Characteristics ID Risk for Recurrent Endoscopic Sinus Surgery

Next Article

Ultraprocessed Food Consumption in Early Childhood Tied to Obesity

Related Posts

Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC

Dual-Targeted Therapies Plus Chemo Improve Objective Re...

Feb 9, 2025  0

2022 to 2023 Saw Decrease in Rate of Drug Overdose Deaths in United States

2022 to 2023 Saw Decrease in Rate of Drug Overdose Deat...

Feb 21, 2025  0

Current Radiologist Shortage Projected to Persist to 2055

Current Radiologist Shortage Projected to Persist to 2055

Feb 27, 2025  0